"A cancer diagnosis can hit you hard. You may feel shock, fear and anger. And you might feel unsure of where to turn for help. You can always turn to us at the Montana Cancer Center at Providence St. Patrick Hospital. We know how to fight the disease, and we know how cancer can affect every part of your life. Our board-certified cancer doctors stay up to date on the latest cancer advances and offer some of the most sophisticated treatments available."

During the past decade, Montana Cancer Center at St. Patrick Hospital and Health Sciences Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 175 clinical trials were completed, i.e. on average, 5833.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 35 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montana Cancer Center at St. Patrick Hospital and Health Sciences Center" #1 sponsor was "SWOG Cancer Research Network" with 84 trials, followed by "Alliance for Clinical Trials in Oncology" with 74 trials sponsored, "National Cancer Institute (NCI)" with 69 trials sponsored, "NSABP Foundation Inc" with 10 trials sponsored and "Eastern Cooperative Oncology Group" with 10 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montana Cancer Center at St. Patrick Hospital and Health Sciences Center" #1 collaborator was "National Cancer Institute (NCI)" with 195 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator, "NCIC Clinical Trials Group" with 15 trials as a collaborator, "Eastern Cooperative Oncology Group" with 14 trials as a collaborator and "SWOG Cancer Research Network" with 12 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Montana Cancer Center at St. Patrick Hospital and Health Sciences Center" are "Breast Cancer" (48 trials), "Lung Cancer" (24 trials), "Lymphoma" (21 trials), "Leukemia" (16 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials). Many other conditions were trialed in "Montana Cancer Center at St. Patrick Hospital and Health Sciences Center" in a lesser frequency.

Most popular intervention types in "Montana Cancer Center at St. Patrick Hospital and Health Sciences Center" are "Drug" (237 trials), "Other" (116 trials), "Biological" (97 trials), "Radiation" (32 trials) and "Procedure" (31 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "placebo" (40 trials), "Bevacizumab" (22 trials), "bevacizumab" (21 trials) and "Paclitaxel" (20 trials). Other intervention names were less common.

The vast majority of trials in "Montana Cancer Center at St. Patrick Hospital and Health Sciences Center" are 213 trials for "All" genders, 54 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Montana Cancer Center at St. Patrick Hospital and Health Sciences Center". undefined are not yet recruiting, 1 are recruiting, 49 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 191 completed trials in Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, undefined suspended trials, and 36 terminated clinical trials to date.

Out of the total trials that were conducted in Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, 9 "Phase 1" clinical trials were conducted, 130 "Phase 2" clinical trials and 127 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".